UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease

PloS one, 2022-12, Vol.17 (12), p.e0277646-e0277646

2022

Volltextzugriff (PDF)

TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation

Scientific reports, 2024-05, Vol.14 (1), p.12389-18, Article 12389

2024

Volltextzugriff (PDF)

Statins synergize with other drugs to prevent myofibroblast transformation in in vitro model of peyronie's disease

Journal of sexual medicine, 2022-11, Vol.19 (11), p.S2-S2

2022

Volltextzugriff (PDF)

Can tamoxifen and a pde5 inhibitor slow the progression of peyronie's disease?

Journal of sexual medicine, 2022-11, Vol.19 (11), p.S15-S16

2022

Volltextzugriff (PDF)

Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats

Diabetes (New York, N.Y.), 2003-09, Vol.52 (9), p.2353-2362

2003

Volltextzugriff (PDF)

Investigating the role of extracellular vesicles in peyronie's disease

Journal of sexual medicine, 2022-11, Vol.19 (11), p.S2-S3

2022

Volltextzugriff (PDF)

Defining a temporal gene expression profile of myofibroblast transformation in peyronie's disease

Journal of sexual medicine, 2022-11, Vol.19 (11), p.S3-S3

2022

Volltextzugriff (PDF)

RhoA/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: A Mechanism for Diabetes-Associated Erectile Dysfunction

Proceedings of the National Academy of Sciences - PNAS, 2004-06, Vol.101 (24), p.9121-9126

2004

Volltextzugriff (PDF)

Associations Between Mobile Health Technology use and Self-rated Quality of Life: A Cross-sectional Study on Older Adults with Cognitive Impairment

Gerontology and geriatric medicine, 2021, Vol.7, p.23337214211018924-23337214211018924

2021

Volltextzugriff (PDF)

Solving a bottleneck in animal models of Peyronie's disease

Asian journal of andrology, 2014-07, Vol.16 (4), p.639-639

2014

Volltextzugriff (PDF)

Solving a bottleneck in animal models of peyronie＇s disease

Asian journal of andrology, 2014, Vol.16 (4), p.639-639

2014

Volltextzugriff (PDF)

P35 Adaptation of a phenotypic screening assay to incorporate 384-well plates: opening the door to high-throughput screening

British journal of dermatology (1951), 2024-05, Vol.190 (6), p.e95-e95

2024

Volltextzugriff (PDF)

P06 A novel drug combination produces a synergistic effect when inhibiting myofibroblast transformation in an in vitro model of hypertrophic scarring

British journal of dermatology (1951), 2024-05, Vol.190 (6), p.e81-e82

2024

Volltextzugriff (PDF)

Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars

European journal of pharmacology, 2024-03, Vol.967, p.176369-176369, Article 176369

2024

Volltextzugriff (PDF)

Physiology of Erectile Function

Journal of sexual medicine, 2004-11, Vol.1 (3), p.254-265

2004

Volltextzugriff (PDF)

P03 Hydroxypyridone antifungals induce myofibroblast apoptosis in an in vitro model of hypertrophic scars

British journal of dermatology (1951), 2023-07, Vol.189 (1), p.e15-e15

2023

Volltextzugriff (PDF)

Demonstration of Functional Neuronal β3 -Adrenoceptors Within the Enteric Nervous System

Gastroenterology (New York, N.Y. 1943), 2007-07, Vol.133 (1), p.175-183

2007

Volltextzugriff (PDF)

Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars

European journal of pharmacology, 2022-12, Vol.937, p.175374-175374, Article 175374

2022

Volltextzugriff (PDF)

The Breakdown of Preformed Advanced Glycation End Products Reverses Erectile Dysfunction in Streptozotocin‐Induced Diabetic Rats: Preventive Versus Curative Treatment

Journal of sexual medicine, 2006-03, Vol.3 (2), p.242-252

2006

Volltextzugriff (PDF)

A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie's disease: the first clinical signals

Journal of sexual medicine, 2023-07, Vol.20 (8), p.1057-1059

2023

Volltextzugriff (PDF)

Characterization of the non‐nitrergic NANC relaxation responses in the rabbit vaginal wall

British journal of pharmacology, 2002-01, Vol.135 (2), p.546-554

2002

Volltextzugriff (PDF)

Unwinding Fibrosis in Peyronie's Disease

Journal of sexual medicine, 2020-05, Vol.17 (5), p.838-840

2020

Volltextzugriff (PDF)

Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's disease

Journal of sexual medicine, 2023-06, Vol.20 (7), p.925-934

2023

Volltextzugriff (PDF)

(109) CONFIRMING ANTI-FIBROTIC EFFECT OF TERFENADINE, EBASTINE, AND SOLIFENACIN IN IN VITRO MODELS OF PEYRONIE’S DISEASE

Journal of sexual medicine, 2023-07, Vol.20 (Supplement_4)

2023

Volltextzugriff (PDF)

(110) EXTRACELLULAR VESICLES ISOLATED FROM PEYRONIE’S DISEASE-DERIVED CELLS CAN ALTER TGF-BETA 1 SIGNALLING CASCADES

Journal of sexual medicine, 2023-07, Vol.20 (Supplement_4)

2023

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(91)
Dissertationen
(1)

Sprache

Englisch
(91)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie's disease

TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation

Statins synergize with other drugs to prevent myofibroblast transformation in in vitro model of peyronie's disease

Can tamoxifen and a pde5 inhibitor slow the progression of peyronie's disease?

Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats

Investigating the role of extracellular vesicles in peyronie's disease

Defining a temporal gene expression profile of myofibroblast transformation in peyronie's disease

RhoA/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: A Mechanism for Diabetes-Associated Erectile Dysfunction

Associations Between Mobile Health Technology use and Self-rated Quality of Life: A Cross-sectional Study on Older Adults with Cognitive Impairment

Solving a bottleneck in animal models of Peyronie's disease

Solving a bottleneck in animal models of peyronie＇s disease

P35 Adaptation of a phenotypic screening assay to incorporate 384-well plates: opening the door to high-throughput screening

P06 A novel drug combination produces a synergistic effect when inhibiting myofibroblast transformation in an in vitro model of hypertrophic scarring

Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars

Physiology of Erectile Function

P03 Hydroxypyridone antifungals induce myofibroblast apoptosis in an in vitro model of hypertrophic scars

Demonstration of Functional Neuronal β3 -Adrenoceptors Within the Enteric Nervous System

Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars

The Breakdown of Preformed Advanced Glycation End Products Reverses Erectile Dysfunction in Streptozotocin‐Induced Diabetic Rats: Preventive Versus Curative Treatment

A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie's disease: the first clinical signals

Characterization of the non‐nitrergic NANC relaxation responses in the rabbit vaginal wall

Unwinding Fibrosis in Peyronie's Disease

Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie's disease

(109) CONFIRMING ANTI-FIBROTIC EFFECT OF TERFENADINE, EBASTINE, AND SOLIFENACIN IN IN VITRO MODELS OF PEYRONIE’S DISEASE

(110) EXTRACELLULAR VESICLES ISOLATED FROM PEYRONIE’S DISEASE-DERIVED CELLS CAN ALTER TGF-BETA 1 SIGNALLING CASCADES

Suchergebnisse filtern